The main purpose of this legislation, known as the HIV Medication Access Act, is to enhance and modify the United States' approach to providing assistance for combating HIV/AIDS. It aims to ensure that certain treatment activities, particularly those involving pre-exposure prophylaxis (PrEP) medications, are recognized as essential humanitarian aid. Key provisions of the Act include several important changes to existing laws. First, it classifies assistance for HIV prevention and treatment, including PrEP, as core life-saving humanitarian assistance.